Most Popular ETFsCrypto ETFsPercent GainersPercent LosersFollowed

News

If a Recession Is Coming, I'm Buying These 4 Top ETFs on the Dipfool.com
Each of these exchange-traded funds offers a different way to make a defensive pivot.
Via The Motley Fool · September 24, 2026
History Says This 1 Investment Could Set You Up for Life. Here's the Math.fool.com
With a trailing-10-year total return of 572%, this popular exchange-traded fund has been a fantastic portfolio addition.
Via The Motley Fool · September 24, 2026
Investing $500 per Month in This Dividend ETF Could Set You Up for Life, According to Historyfool.com
With enough time and discipline, even small monthly investments can turn into $1 million or more over time.
Via The Motley Fool · September 24, 2026
Interest Rates Are Rising. Here's the ETF I'd Buy to Profit From It.fool.com
Look to sectors that actually benefit from higher interest rates.
Via The Motley Fool · September 24, 2026
Outer Space vs. Air Space Stocks: Is the ARKX ETF a Better Investment Than the JETS ETF?fool.com
ARKX holds 60% industrials with space-tech leaders like SpaceX, while JETS concentrates on airlines.
Via The Motley Fool · September 24, 2026
What Happens After a Real-World Asset Becomes a Token?talkmarkets.com
Real-world asset tokenization is moving beyond the idea of simply putting ownership records on a blockchain. The more important question begins after the t
Via Talk Markets · September 24, 2026
Vanguard Real Estate ETF vs State Street SPDR: Diversification or Costfool.com
Vanguard is more diversified with a higher dividend yield, while State Street's concentrated 30-stock portfolio charges a lower expense ratio.
Via The Motley Fool · September 23, 2026
Anheuser-Busch InBev Targets 5% to 9% Annual EBIT Growth in Reignite Phasemarketbeat.com
Anheuser-Busch InBev SA/NV (NYSE:BUD) outlined a new medium-term target for 5% to 9% average annual EBIT growth as the brewer shifts its primary performance measure from EBITDA to EBIT, citing improved balance-sheet strength, capital efficiency and an increased focus on organic growth. Speaking at
Via MarketBeat · September 23, 2026
Everpure Unveils Data-First AI Strategy, Targets $21B Intelligence Marketmarketbeat.com
Everpure (NYSE:P) outlined an expanded technology strategy centered on what executives called “data primacy,” arguing that artificial intelligence is pushing enterprises to organize IT architectures around data rather than individual applications. At its financial analyst meeting in Santa Clara, Ch
Via MarketBeat · September 23, 2026
Everpure Maps AI, Hyperscale Push as It Targets $7B in Fiscal 2028 Revenuemarketbeat.com
Everpure (NYSE:P) outlined a strategy centered on expanding its enterprise storage business while pursuing new opportunities in AI infrastructure, data software and hyperscale deployments, with executives projecting accelerated growth and higher profitability through fiscal 2028. At the company’s i
Via MarketBeat · September 23, 2026
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocksfool.com
XLV's broader diversification and lower fees appeal to cost-conscious investors, while PJP's concentrated pharma bet has outperformed over the past year.
Via The Motley Fool · September 23, 2026
Here's How Much You'd Need to Invest in SCHD to Generate $500 Per Month in Dividendsfool.com
SCHD also has one of the best track records of growing over time too.
Via The Motley Fool · September 23, 2026
Want to Add Instant Diversification to Your Portfolio? Here's How VT and VWO Stack Up.fool.com
VT holds more than 10,000 stocks across global markets while VWO focuses on more than 6,000 emerging-market holdings. VT delivered stronger five-year returns despite a lower dividend yield.
Via The Motley Fool · September 23, 2026
Better Consumer Staples ETF: Vanguard's VDC vs. State Street's XLPfool.com
State Street offers a higher yield and lower costs, but Vanguard's broader portfolio of 103 holdings delivered stronger five-year returns.
Via The Motley Fool · September 23, 2026
This “Diversified” Vanguard ETF Is at Its Most Concentrated Point Since 1965. Here's What That Means for VOO Investors.fool.com
The S&P 500's current concentration has its benefits and risks.
Via The Motley Fool · September 23, 2026
If I Could Only Buy and Hold 1 ETF for the Next 20 Years, Here's Where I'd Investfool.com
Vanguard's S&P 500 ETF is still my top recommendation for passive investors.
Via The Motley Fool · September 23, 2026
Better Energy Sector ETF: Vanguard's VDE Focused on Oil and Gas vs. the iShares ICLN Targeting Clean Energyfool.com
VDE's traditional oil holdings delivered 46.8% returns over one year, while ICLN's renewable focus saw deeper volatility and a 57.2% maximum drawdown.
Via The Motley Fool · September 23, 2026
This Dividend King Was Removed From the S&P 100. Here's Why It's a Great Buy for Long-Term Investors Anyway.fool.com
Colgate-Palmolive's removal from the index doesn't indicate its business is crumbling.
Via The Motley Fool · September 23, 2026
2 Things Canadian Investors Need to Know From This Week’s Investment Summit and Fed Headlinesfool.ca
Vanguard FTSE Canada All Cap Index ETF (TSX:VCN) could be a long-term winner as Canada becomes more attractive following the latest investment summit.
Via The Motley Fool · September 23, 2026
Vanguard S&P 500 ETF Long-Term Outlook: What History Tells Investorsfool.com
The S&P 500 has been perhaps the greatest wealth generation machine of the past several decades.
Via The Motley Fool · September 23, 2026
If a Recession Is Coming, This Dividend ETF Could Be the Smartest Long-Term Buy Right Nowfool.com
The State Street SPDR S&P Dividend ETF could be the ideal dividend fund if the U.S. economy cools.
Via The Motley Fool · September 23, 2026
This ETF Is Up 20% in 2026. Here's Why It Could Have More Room to Run.fool.com
Invesco's QQQ Trust is still one of the easiest ways to beat the market.
Via The Motley Fool · September 23, 2026
AGF Management Q3 Earnings Call Highlightsmarketbeat.com
AGF Management (TSE:AGF.B) reported third-quarter 2026 adjusted diluted earnings per share of CAD 0.49, adjusted EBITDA of CAD 49 million and free cash flow of CAD 39 million, as growth in assets under management and retail sales momentum supported results. Chief Executive Officer Judy Goldring sai
Via MarketBeat · September 23, 2026
Regeneron Highlights EYLEA HD Momentum, Dupixent Growth and Pipeline Catalystsmarketbeat.com
Regeneron Pharmaceuticals (NASDAQ:REGN) executives highlighted continued growth across key marketed products, a broad late-stage pipeline and an ongoing focus on science-driven business development during a discussion with Bernstein analyst Jeffrey Walch. Chris Fenimore, Regeneron’s executive vice
Via MarketBeat · September 23, 2026
This Unstoppable ETF Is Down 12% From Its High -- and History Says Now Is a Smart Time to Investfool.com
There are not many ETFs that can match this ETF on performance.
Via The Motley Fool · September 23, 2026